mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.04 |
mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.04 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.098 |
0.04 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.04 |
mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.05 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.05 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.05 |